The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway
The pathogenic mechanisms of pancreatic cancer (PC) are still not fully understood. Ubiquitination modifications have a crucial role in tumorigenesis and progression. Yet, the role of MINDY2, a member of the motif interacting with Ub-containing novel DUB family (MINDY), as a newly identified deubiqu...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1169833/full |
_version_ | 1797834699920375808 |
---|---|
author | Peng Liu Peng Liu Songbai Liu Changhao Zhu Yongning Li Ying Li Xiaobin Fei Junyi Hou Xing Wang Xing Wang Yaozhen Pan Yaozhen Pan |
author_facet | Peng Liu Peng Liu Songbai Liu Changhao Zhu Yongning Li Ying Li Xiaobin Fei Junyi Hou Xing Wang Xing Wang Yaozhen Pan Yaozhen Pan |
author_sort | Peng Liu |
collection | DOAJ |
description | The pathogenic mechanisms of pancreatic cancer (PC) are still not fully understood. Ubiquitination modifications have a crucial role in tumorigenesis and progression. Yet, the role of MINDY2, a member of the motif interacting with Ub-containing novel DUB family (MINDY), as a newly identified deubiquitinating enzyme, in PC is still unclear. In this study, we found that MINDY2 expression is elevated in PC tissue (clinical samples) and was associated with poor prognosis. We also found that MINDY2 is associated with pro-carcinogenic factors such as epithelial-mesenchymal transition (EMT), inflammatory response, and angiogenesis; the ROC curve suggested that MINDY2 has a high diagnostic value in PC. Immunological correlation analysis suggested that MINDY2 is deeply involved in immune cell infiltration in PC and is associated with immune checkpoint-related genes. In vivo and in vitro experiments further suggested that elevated MINDY2 promotes PC proliferation, invasive metastasis, and EMT. Meanwhile, actinin alpha 4 (ACTN4) was identified as a MINDY2-interacting protein by mass spectrometry and other experiments, and ACTN4 protein levels were significantly correlated with MINDY2 expression. The ubiquitination assay confirmed that MINDY2 stabilizes the ACTN4 protein level by deubiquitination. The pro-oncogenic effect of MINDY2 was significantly inhibited by silencing ACTN4. Bioinformatics Analysis and Western blot experiments further confirmed that MINDY2 stabilizes ACTN4 through deubiquitination and thus activates the PI3K/AKT/mTOR signaling pathway. In conclusion, we identified the oncogenic role and mechanism of MINDY2 in PC, suggesting that MINDY2 is a viable candidate gene for PC and may be a therapeutic target and critical prognostic indicator. |
first_indexed | 2024-04-09T14:42:50Z |
format | Article |
id | doaj.art-d5709f8042224d4e909d95ef8e83989f |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-04-09T14:42:50Z |
publishDate | 2023-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-d5709f8042224d4e909d95ef8e83989f2023-05-03T05:23:06ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-05-011310.3389/fonc.2023.11698331169833The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathwayPeng Liu0Peng Liu1Songbai Liu2Changhao Zhu3Yongning Li4Ying Li5Xiaobin Fei6Junyi Hou7Xing Wang8Xing Wang9Yaozhen Pan10Yaozhen Pan11College of Clinical Medicine, Guizhou Medical University, Guiyang, ChinaDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaCollege of Clinical Medicine, Guizhou Medical University, Guiyang, ChinaDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, ChinaDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, ChinaCollege of Clinical Medicine, Guizhou Medical University, Guiyang, ChinaCollege of Clinical Medicine, Guizhou Medical University, Guiyang, ChinaCollege of Clinical Medicine, Guizhou Medical University, Guiyang, ChinaDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, ChinaCollege of Clinical Medicine, Guizhou Medical University, Guiyang, ChinaDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, ChinaThe pathogenic mechanisms of pancreatic cancer (PC) are still not fully understood. Ubiquitination modifications have a crucial role in tumorigenesis and progression. Yet, the role of MINDY2, a member of the motif interacting with Ub-containing novel DUB family (MINDY), as a newly identified deubiquitinating enzyme, in PC is still unclear. In this study, we found that MINDY2 expression is elevated in PC tissue (clinical samples) and was associated with poor prognosis. We also found that MINDY2 is associated with pro-carcinogenic factors such as epithelial-mesenchymal transition (EMT), inflammatory response, and angiogenesis; the ROC curve suggested that MINDY2 has a high diagnostic value in PC. Immunological correlation analysis suggested that MINDY2 is deeply involved in immune cell infiltration in PC and is associated with immune checkpoint-related genes. In vivo and in vitro experiments further suggested that elevated MINDY2 promotes PC proliferation, invasive metastasis, and EMT. Meanwhile, actinin alpha 4 (ACTN4) was identified as a MINDY2-interacting protein by mass spectrometry and other experiments, and ACTN4 protein levels were significantly correlated with MINDY2 expression. The ubiquitination assay confirmed that MINDY2 stabilizes the ACTN4 protein level by deubiquitination. The pro-oncogenic effect of MINDY2 was significantly inhibited by silencing ACTN4. Bioinformatics Analysis and Western blot experiments further confirmed that MINDY2 stabilizes ACTN4 through deubiquitination and thus activates the PI3K/AKT/mTOR signaling pathway. In conclusion, we identified the oncogenic role and mechanism of MINDY2 in PC, suggesting that MINDY2 is a viable candidate gene for PC and may be a therapeutic target and critical prognostic indicator.https://www.frontiersin.org/articles/10.3389/fonc.2023.1169833/fullpancreatic cancerMINDY2deubiquitinating enzymeACTN4PI3K/AKT/mTOR |
spellingShingle | Peng Liu Peng Liu Songbai Liu Changhao Zhu Yongning Li Ying Li Xiaobin Fei Junyi Hou Xing Wang Xing Wang Yaozhen Pan Yaozhen Pan The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway Frontiers in Oncology pancreatic cancer MINDY2 deubiquitinating enzyme ACTN4 PI3K/AKT/mTOR |
title | The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway |
title_full | The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway |
title_fullStr | The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway |
title_full_unstemmed | The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway |
title_short | The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway |
title_sort | deubiquitinating enzyme mindy2 promotes pancreatic cancer proliferation and metastasis by stabilizing actn4 expression and activating the pi3k akt mtor signaling pathway |
topic | pancreatic cancer MINDY2 deubiquitinating enzyme ACTN4 PI3K/AKT/mTOR |
url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1169833/full |
work_keys_str_mv | AT pengliu thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT pengliu thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT songbailiu thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT changhaozhu thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT yongningli thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT yingli thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT xiaobinfei thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT junyihou thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT xingwang thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT xingwang thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT yaozhenpan thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT yaozhenpan thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT pengliu deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT pengliu deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT songbailiu deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT changhaozhu deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT yongningli deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT yingli deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT xiaobinfei deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT junyihou deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT xingwang deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT xingwang deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT yaozhenpan deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway AT yaozhenpan deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway |